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Abstract: To evaluate the expression of the epidermal growth factor receptor (EGFR) 
and mean vascular density (MVD) in normal oral mucosa (NOM), oral epithelial 
dysplasia (OED) and oral squamous cell carcinoma (OSCC). Material and methods: 
Descriptive case study. Nineteen histological samples diagnosed with NOM, 18 diag-
nosed with OED, and 19 with OSCC, were analyzed with immunohistochemistry 
against EGFR and CD31. EGFR expression was evaluated by extent and intensity of 
its expression in normal, dysplastic and neoplastic epithelium. MVD was determined 
through the detection of blood vessels by antibodies against CD31. Results: Extension 
of EGFR expression was highest in OSCC followed by OED and lowest in NOM, 
resulting in significant different between the degrees of extension (p<0.001). Intensity 
of EGFR was similar in NOM, OED and OSCC, without differences in its expres-
sion (p=0.533). Differences in MVD were found between NOM and OSCC groups 
(p<0.01), and between OED and OSCC groups (p<0.01), with no differences between 
NOM and OED groups (p=0.91). MVD was 21.17±4.98 in NOM, 23.40±5.77 in 
OED and 33.92±8.39 in OSCC. Conclusion: EGFR is expressed in normal, dysplastic 
or neoplastic oral epithelium. However, the extent of its expression is greater as malig-
nancy increases. MVD varies according to the diagnosis.
Keywords: Oral cavity, mouth neoplasms, epidermal growth factor receptor, 
pathologic angiogenesis.
INTRODUCTION.
Oral squamous cell carcinoma (OSCC) is the most common malignant 
neoplasm of the oral cavity. 1 An incidence of 500,000 cases per year has been 
reported worldwide.2 OSCC may originate from malignant transformation 
of normal oral mucosa (NOM), and from potentially malignant lesions with 
different degrees of oral epithelial dysplasia (OED).3,4
The genesis of malignant neoplasms, such as OSCC, is a complex process 
involving a breakdown in the regulation pathways of cell division, differentiation, 
death and angiogenesis.2 In this regard, protooncogenes are the physiological 
regulators of proliferation and differentiation of normal cells. Overexpression 
of their mutated counterparts, the oncogenes, plays a key role in carcinogenesis. 
Oncogenes encode, among others, growth factor receptors, which may cause 
uncontrolled cell proliferation. In the case of carcinomas, one key receptor 
is the epidermal growth factor receptor (EGFR).5 Its mutation stimulates 
mitosis and inhibits the apoptosis of neoplastic keratinocytes.6 This receptor is 
expressed both in normal epithelia and in those subjects with pathologies such 
as epithelial dysplasia and carcinomas, where proliferation and differentiation of 
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keratinocytes are altered.7
The complex interaction between neoplastic cells and 
their environment plays a central role in carcinogenesis, as 
environmental changes may facilitate cell growth, invasion 
and metastasis. In the case of OSCC, the microenvironment 
consists of fibroblasts, deposits of the extracellular matrix, 
immune system cells, lymphatic vessels and blood vessels. 
The vascular system supplies oxygen and nutrients to the 
neoplastic cells. In addition, newly formed endothelial cells 
secrete growth factors that act on themselves and on adjacent 
neoplastic cells stimulating their proliferation.8,9 Malignant 
neoplasms induce angiogenesis in a volume up to 2-3 mm³ and 
this value represents the critical distance by which nutrients 
and oxygen can diffuse from the blood vessels.10 Therefore, the 
understanding of angiogenesis is critical to comprehend the 
malignant transformation of epithelial lesions of the oral cavity 
such as OED or OSCC.11,12
CD31 is one of the most important molecular markers 
for evaluating angiogenesis, through the calculation of the 
mean vascular density (MVD). CD31 is a protein present in 
the intercellular junction of endothelial cells in developing or 
already developed blood vessels.13
The aim of this study was to evaluate EGFR expression and 
angiogenesis, through the mean vascular density (MVD), in 
NOM, OED and OSCC.
MATERIALS AND METHODS.
A descriptive case study was designed. The study was appro-
ved by the Bioethics Committee of Universidad Andrés Bello 
(Folio No 033). Participants were asked to sign an informed 
consent.
Sample collection
Nineteen samples diagnosed with NOM, 18 diagnosed 
with OED, and 19 with OSCC, were collected. Samples of 
NOM were obtained from alveolar ridge mucosa of mandibu-
lar third molars, from individuals who had undergone surgery 
at the School of Dentistry of Universidad Andrés Bello, Viña 
del Mar, between March and July 2014. Samples of OED and 
OSCC were obtained from paraffin-embedded samples co-
llected between 2004 and 2012 by the Oral Histopathology 
Service at the School of Dentistry, Universidad Andrés Bello, 
Viña del Mar.
Inclusion and exclusion criteria for sample selection
Inclusion criteria included paraffin-embedded samples 
with enough tissue to obtain three histological section of 4 
microns each, diagnosed histologically with NOM, OED or 
OSCC, with information regarding the patient’s age, gender 
and place of residence. All age ranges, both sexes and location 
of the lesion in the oral mucosa were included. Exclusion cri-
teria consisted of OSCC samples from secondary to metastasis 
stage and histological lamellae with methodological artifacts.
Confirming diagnosis of the samples
To confirm the diagnosis of NOM, OED and OSCC of 
the selected samples, two independent, previously standardi-
zed and calibrated pathologists examined hematoxylin-eosin 
stained sections under Olympus® CX-31 light microscopy 
(Olympus Corporation, Japan). In order to make the diagno-
sis, they considered the criteria proposed by the World Health 
Organization in a double-blind examination.14,15
Immunohistochemistry technique for EGFR
Four micron sections were obtained and mounted on xyla-
nized, dewaxed slides and hydrated with distilled water. Once 
hydrated, an antigenic recovery process was performed on a 
steamer using citrate buffer, pH 6. The endogenous peroxi-
dase enzyme was then blocked by the application of 3% v/v 
hydrogen peroxide. Sections were incubated overnight with 
rabbit anti-EGFR monoclonal antibody (diluted 1: 100; Ven-
tana Medical System Inc, Tucson Arizona, USA). Immunos-
taining was performed with Envision system (Dako, Santa 
Clara, USA.) according to the manufacturer’s instructions. 
Peroxidase activity was measured by the application of the 
diaminobenzidine chromogen substrate.
Immunohistochemistry technique for CD31
Samples were processed as described for the immunohis-
tochemistry of EGFR, but were placed on a poly-L-lysine 
coated slide (BioSB, Santa Barbara, USA). These sections 
were incubated with human CD-31 monoclonal antibody 
(Clone JC70A, IgG-1, kappa, Dako, Carpenteria, Califor-
nia, USA), diluted 1:40, using the avidin-biotin-peroxidase 
complex detection method, at a temperature of 37°C for 32 
minutes. Antigenic recovery was performed at 95-100°C 
for 60 minutes with CC1 Standard solution (Cell Condi-
tioning Solution-1, Ventana Medical Systems, Inc.).
Evaluation of immunostained samples against 
EGFR
Samples were analyzed by two blind calibrated exa-
miners (RM and AF). Immunopositive cells for EGFR 
were those that presented membrane and/or cytoplas-
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Table 1. Distribution of patients by their demographic variables and clinical characteristics.
NOM: normal oral mucosa; OED: oral epithelial dysplasia; OSCC: Oral squamous cell carcinoma.
mic staining, compared with negative and positive 
controls placed on the same slide. The positive control 
consisted of a segment of placenta analyzed with the 
complete immunohistochemical technique for EGFR. 
The negative control was obtained by omission of the 
primary antibody.
The intensity of immunostaining of EGFR in NOM, 
OED and OSCC was qualitatively evaluated and cate-
gorized nominally and arbitrarily into 0: negative im-
munostaining, 1: mild immunostaining, 2: moderate 
immunostaining and 3: marked immunostaining. The 
extent of EGFR immunostaining in the epithelial thic-
kness of NOM, OED and OSCC was categorized as 
0=0%; 1=1 to 25%; 2=26-50%; 3=51-75%; 4=75-100%.
Evaluation of immunostimulated samples against 
CD31
Samples were analyzed by two blind calibrated exa-
miners (RM and AF). Any tubular structure coated by 
endothelial cells, individual endothelial cells or in is-
lets immunoreactive with the antibody against CD31, 
was considered as a blood vessel. Each sample was 
compared with a positive and negative control in each 
histological slides. The positive control consisted of a 
segment of angiosarcoma stained with the complete 
immunohistochemical technique against CD31. The 
immunonegative control was obtained by omission of 
the primary antibody.
To determine MVD, samples were observed under an 
Olympus® CX-31 light microscope (Olympus Corpora-
tion, Japan), and 3 consecutive hot spots were selected 
that corresponded to the areas of greatest vasculariza-
tion. Each hot spot was photographed at 40x magnifi-
cation, using a 5.1 megapixel Micrometrics® Model 518 
CU digital camera built into the microscope. In each 
image blood vessels were counted (20x objective lens 
and 10x ocular lens, 0.7386 mm2/field).
MVD of each sample was determined using the fo-
llowing formula: MVD=(Number of vessels in Hot spot 
1+ Number of vessels in Hot spot 3 + No of Hot spot 3 
vessels)/3.
Statistical analysis.
Parametric and non-parametric tests were performed 
according to the nature of the variables. Kruskal-Wallis 
test was used for the analysis of the extent and intensi-
ty of EGFR according to diagnosis, and Conover-Iman 
post-hoc test was performed to evaluate differences in 
the range averages. The comparison of the mean number 
of vessels according to diagnosis was performed using 
ANOVA, with Bonferroni post hoc test. Student’s t-test 
of independent samples was used to evaluate the rela-
tionship between EGFR extension and the number of 
vessels. Statistical significance was set at p<0.05. Sta-
tistical analysis was performed with STATA 12® (Stata-
CorpLP, Texas, USA).
RESULTS.
The number of samples included in the study, age and 
gender distribution, for each diagnosis and the totality of 
the samples, are shown in Table 1.
Regarding EGFR expression by extension and intensity 
(Figure 1, Table 2), there was a difference in the extent of 
EGFR expression when comparing each diagnostic group 
(p<0.001). In contrast, no differences were found in the 
intensity of detected EGFR when comparing each diagnos-
tic group (p=0.533). On the other hand, when analyzing 
OSCC samples according to their degree of differentiation, 
 NOM OED OSCC Total sample
Number of samples 19 18 18 56
Median age (years) 22 56 73 55.5
Interquartile range (years) 17 to 25 49 to 65 65 to 82 25 to 65.7
Frequency of females % 73.68 26.32 50 50
Frequency of males % 57.89 42.11 60.71 39.2
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   Extension    Intensity
  2 3 4  1 2 3
  26-50% 51-75% 476-100%  Mild Moderate Marked
 n (%)          n (%)      n (%) n (%) n (%)  n (%)
NOM 1 (5.26) 18  (94.74) - - - -  11 (57.89) 8 (42.11)
OED - - 14  (77.78) 4  (22.22) 1 (5.56)        12 (55.56) 7 (38.89) 
OSCC - - 2  (10.53) 17  (89.17) 1 (5.26) 7 (36.84) 11  (57.89)
Figure 1. EGFR expression (Brown) in normal oral mucosa (A) and, oral epithelial dysplasia (B:) mild (C) and marked (D). 
Oral squamous cell carcinoma: well differentiated (E) and poorly differentiated (F). 10x magnification.
Figure 2. Expression (Brown) of CD31 showing blood vessels in normal oral mucosa (A), mild oral epithelial dysplasia (B), 
and oral squamous cell carcinoma (C) and (D). 10x magnification.
Table 1. Comparison of the extent and intensity of EGFR expression in normal oral mucosa, 
oral epithelial dysplasia and oral squamous cell carcinoma.
NOM: normal oral mucosa; OED: oral epithelial dysplasia; OSCC: Oral squamous cell carcinoma.
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no differences were found in the intensity and extent of 
EGFR (p=0.704 and p=0.816, respectively).
Regarding MVD (Figure 2), a mean of 21.17±4.98 ves-
sels were observed in NOM, 23.40±5.77 vessels in OED, 
and 33.92±8.39 vessels in OSCC. The MVD was different 
between NOM and OSCC (p<0.01) and between OED 
and OSCC (p<0.01). However, no differences were found 
between NOM and OED groups (p=0.91).
By relating MVD and the extent of EGFR expression in 
categories 3 and 4, at category 3 of EGFR expression there 
was a mean of 22.79±6.65 vessels, and at category 4 there 
was a mean of 31.55±8.83 vessels (p<0.001). In contrast, no 
differences were found between the number of vessels and 
the EGFR expression (p=0.351).
DISCUSSION.
In the last decade, interest has increased in identifying 
markers that may allow prediction of malignant trans-
formation of normal and dysplastic oral epithelium into 
an OSCC.7 This is due to the fact that even in spite of 
advances in scientific knowledge, the histopathological 
diagnosis remains the gold standard for making diagnos-
tic and therapeutic decisions, which does not allow the 
prediction of how an oral lesion will evolve.22
It was found that dysplastic lesions of the oral mucosa 
preceded the neoplastic epithelial pathology, which co-
incides with that reported in the literature.23,24 This may 
be because the pathogenesis of both OED and OSCC is 
associated with the same carcinogenic stimuli. However, 
in OSCC, it is associated with a long accumulation of its 
effects.25,26 In the OED group, no gender bias was found. 
However, a higher frequency of OSCC was found among 
women. There is controversy as to which sex is most af-
fected. This could be explained by region specific habits, 
such as chewing tobacco or betel nut.23-26,27
Regarding evaluation of EGFR, authors such as Rössle 
et al.6 and Rajesweri et al.28 and the authors of this study 
found that in all the samples analyzed, regardless of di-
agnosis, immunostaining of EGFR was always positive. 
However, there were variations in its intensity range. The 
extension of EGFR expression in the NOM group was 
mainly of type 3, reflecting that EGFR was expressed 
more in the basal, suprabasal and spinosum strata, disap-
pearing in the superficial stratum, which coincides with 
that described in the literature.28,29 The intensity of EGFR 
was mainly moderate and marked, which coincides with 
Rajesweri et al.28 These results can be explained because 
EGFR is expressed in proliferating epithelial cells, such 
as in the basal stratum, and its expression is lost in the 
superficial or corneous stratum where the prevalence of 
proliferative cells decrease.17 Unlike the NOM group, 
EGFR expression in the OED group in some samples 
involved even the stratum corrneum, which may be due 
to an increase in normal proliferative activity, although 
in an irregular growth pattern.28 Its intensity was catego-
rized as “marked”, similarly to that of the NOM group, 
coinciding with the data reported in the literature.29 In 
the OSCC samples, it was found that in most cases the 
extension of EGFR covered the entire sample and its in-
tensity was defined as “marked” in a high percentage. 
Rössle et al.6 and Sarkis et al.8 reported similar findings. 
From this data, it could be inferred that the extent and in-
tensity found for EGFR in carcinomas would be revealing 
a completely uncontrolled growth of neoplastic epithelial 
cells12 and that the extent of EGFR expression is higher as 
malignancy increases.
In the present study, no difference was found between 
intensity and extent of EGFR regarding different degrees 
of OSCC differentiation, coinciding with Ragomir et al.30 
This fact may indicate that EGFR is not related to the 
degree of differentiation of neoplastic keratinocytes. Al-
though Sarkis et al.12 and Laimer et al.,20 consider that 
both the extent and intensity of EGFR reflect an alter-
ation in the regulation of cell proliferation. The results of 
this study suggest that the alteration of cell proliferation 
would be mainly represented by the number of cells af-
fected and not by expression intensity.
In the 1970s the growth of tumors was associated with 
angiogenesis for the first time. The most important pro-
angiogenic factor is VEGF and its activation may be posi-
tively regulated by EGFR.31 We found that MVD showed 
a tendency to increase from NOM to OSCC. This differ-
ence was significant when comparing MVD of NOM and 
OSCC diagnoses and the diagnosis of OED and OSCC. 
This suggests that the angiogenic phenotypic change could 
occur mainly in OSCC rather than OED.9 Other authors 
such as Sathyakumar et al.32 Basnaker et al.33 also studied 
MVD in samples with NOM, OED and OSCC diagnoses, 
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but used different types of markers for blood vessels. How-
ever, it should be noted that most of the studies, indepen-
dent of the marker used, coincide with the results of this 
study in relation to the increase in MDV in the transition 
from NOM to OED to OSCC.
To our knowledge, the association between EGFR and 
CD31 expression has not been previously studied in oral 
samples of NOM, OED and OSCC. This study demon-
strates that when the EGFR extent was greater than 50%, 
independent of its diagnosis, MDV increased. These re-
sults suggest that EGFR could positively regulate angio-
genesis, probably via secretion of growth factors. a recent 
publication showed that a decrease in EGFR was involved 
in the decrease of VEGF expression and that the activa-
tion of EGFR-VEGF favored angiogenesis in hepatocel-
lular carcinoma.34
Some consideration should be given to the limitations 
of this study, such as sample size, due to the fact that 
OSCC is a low prevalence pathology1 and the large differ-
ence in the age range of subjects in the NOM group, when 
compared to subjects in the OED and OSCC groups. The 
latter could be explained by the samples of NOM, which 
were obtained from mucosa that included third molars.
CONCLUSION.
EGFR is expressed in normal, dysplastic or neoplastic 
oral epithelium. However, the extent of its expression is 
greater as malignancy increases. MVD varies according to 
the diagnosis.
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